(Q46782395)

25 December 2017

title

Levetiracetam monotherapy for adults with localization-related epilepsy (English)

1 reference

25 December 2017

1 reference

Taoufik M. Alsaadi

1

1 reference

25 December 2017

Catherine Thieman

series ordinal

2

1 reference

25 December 2017

Edie E. Zusman

series ordinal

3

1 reference

25 December 2017

publication date

1 October 2002

1 reference

25 December 2017

published in

Epilepsy Behavior

1 reference

25 December 2017

volume

3

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

471-474

1 reference

25 December 2017

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

Epilepsy after the first drug fails: substitution or add-on?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

Levetiracetam psychosis in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900516-4

7 January 2021

10.1016/S1525-5050(02)00516-4

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017